# Once Weekly Parathyroid Hormone for Osteoporosis

> **NCT00065637** · PHASE3 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 50 (—)

## Conditions studied

- Osteopenia
- Osteoporosis

## Interventions

- **DRUG:** Teriparatide
- **DRUG:** Placebo teriparatide

## Key facts

- **NCT ID:** NCT00065637
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 50 (—)
- **Last updated:** 2013-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00065637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00065637, "Once Weekly Parathyroid Hormone for Osteoporosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00065637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*